Statistics for Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?
Total visits
| views | |
|---|---|
| Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country? | 268 |
Total visits per month
| views | |
|---|---|
| December 2024 | 10 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| 16534.pdf(legacy) | 155 |
| 16534.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 101 |
| China | 56 |
| Russia | 45 |
| Australia | 17 |
| Canada | 11 |
| Mongolia | 8 |
| Germany | 7 |
| Portugal | 6 |
| India | 4 |
| Brazil | 3 |
| South Korea | 2 |
| Ukraine | 2 |
| Argentina | 1 |
| France | 1 |
| Hong Kong SAR China | 1 |
| Italy | 1 |
| Japan | 1 |